Financial Highlights
Revenue: $8,254,652 (YoY -15.85%, QoQ -19.88%)
Gross Profit: $2,064,190; Gross Margin: 25.01%
Operating Income: $1,092,970; Operating Margin: 13.24%
EBITDA: $1,203,270; EBITDA Margin: 14.58%
Net Income: $1,031,930; Net Margin: 12.50%
EPS: $0.41 (Diluted $0.40); Weighted Avg Shs Out: 2,491,906; Diluted: 2,571,921
Operating Cash Flow: $1,411,507; Free Cash Flow: $379,140
Capex: $(1,032,367); Free Cash Flow to Equity: N/A
Cash, Cash Equivalents: $5,556,264; Short-Term Investments: $15,568,474; Total Cash & ST Investments: $21,124,738
Total Current Assets: $50,384,089; Total Assets: $53,137,888
Total Current Liabilities: $13,795,938; Total Liabilities: $13,795,938; Total Stockholdersβ Equity: $39,341,950
Net Debt: $(5,556,264) (net cash)
Current Ratio: 3.65; Quick Ratio: 2.23; Cash Ratio: 0.40
Days Sales Outstanding: 57.95; Days Inventory Outstanding: 285.12; Cash Conversion Cycle: 301.85; Days Payables Outstanding: 41.23
Gross Margin: 0.250; Operating Margin: 0.132; Pretax Margin: 0.155; Net Margin: 0.125
Payout Ratio: 0.423; Price to Book: 1.609; P/E: 15.33; Price/Sales: 7.67
Dividend Yield: 0.689%
Note: The QQ3 2024 dataset shows no disclosed R&D or SG&A line items in reported figures, and ratios are sourced from the provided data.
Income Statement
| Metric |
Value |
YoY Change |
QoQ Change |
| Revenue |
8.25M |
-15.85% |
-19.88% |
| Gross Profit |
2.06M |
4.60% |
-34.32% |
| Operating Income |
1.09M |
14.01% |
-47.78% |
| Net Income |
1.03M |
18.98% |
-42.52% |
| EPS |
0.41 |
17.14% |
-43.06% |